XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net (loss) income $ (1,264,000) $ 1,648,000
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 300,000 14,000
Amortization of deferred financing costs 12,000 0
Changes in allowance for doubtful accounts 0 20,000
Stock-based compensation expense 1,000 22,000
Noncash operating lease expense 143,000 0
Deferred income tax (benefit) expense (505,000) 0
Increase (decrease) in cash resulting from changes in, net of acquisition:    
Accounts receivable, net (1,635,000) (3,770,000)
Inventories 3,322,000 5,000
Income tax receivable 0 2,000
Prepaid expenses and other current assets (1,037,000) (1,084,000)
Accounts payable 263,000 (440,000)
Accrued compensation (645,000) 0
Accrued expenses and other current liabilities 2,429,000 (137,000)
Deferred revenue 0 (126,000)
Net cash provided by (used in) operating activities of continuing operations 1,384,000 (3,846,000)
Net cash provided by operating activities of discontinued operations 86,000 0
Net cash provided by (used in) operating activities 1,470,000 (3,846,000)
Investing Activities    
Purchases of property and equipment (230,000) (6,000)
Acquisition of Bloomia, net of cash acquired (34,178,000) 0
Receipts from note receivable 36,000 0
Net cash used in investing activities (34,372,000) (6,000)
Financing Activities    
Proceeds from long-term debt 24,000,000 0
Repayments of long-term debt (1,650,000) 0
Principal payments on finance lease liabilities (2,000) 0
Payment of financing costs (513,000) 0
Proceeds from issuances of common stock 0 8,000
Net cash provided by financing activities 21,835,000 8,000
Effect of exchange rate changes 3,000 0
Net decrease in cash and cash equivalents (11,064,000) (3,844,000)
Cash and cash equivalents, beginning of period 16,077,000 14,524,000
Cash and cash equivalents, end of period 5,013,000 10,680,000
Supplemental cash flow information    
Cash paid for interest 46,000 0
Noncash purchase consideration - Equity issuance of noncontrolling interest 2,990,000 0
Noncash purchase consideration - Seller notes $ 15,451,000 $ 0